US 7919079
Cancer immunotherapy compositions and methods of use
granted A61KA61K2039/505A61K2039/5152
Quick answer
US patent 7919079 (Cancer immunotherapy compositions and methods of use) held by The Regents of the University of California expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Apr 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K2039/505, A61K2039/5152, A61K2039/55516, A61K2039/55522